• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术支架置入后肌减少症的逆转预测生存。

Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.

机构信息

Departments of Gastroenterology, Hepatology and Pathobiology, Cleveland Clinic, Cleveland, Ohio, USA.

出版信息

Eur J Gastroenterol Hepatol. 2013 Jan;25(1):85-93. doi: 10.1097/MEG.0b013e328359a759.

DOI:10.1097/MEG.0b013e328359a759
PMID:23011041
Abstract

BACKGROUND

Sarcopenia is the most frequent complication of cirrhosis. A transjugular intrahepatic portosystemic stent (TIPS) lowers portal pressure in cirrhosis and alters the body composition. Changes in the skeletal muscle area and adipose tissue volume were quantified by computed tomography (CT) before and after TIPS.

MATERIALS AND METHODS

Fifty-seven consecutive cirrhotics who had a CT scan before and after TIPS were studied. Simultaneous age-matched, sex-matched, Child's score-matched, and Model for End-Stage Liver Disease score-matched cirrhotics (n=32) who did not undergo TIPS comprised the disease control and 57 healthy individuals who had undergone CT abdomen comprised the healthy control population. Muscle area and fat volume were obtained at the mid-L4 vertebra level on the CT scans.

RESULTS

Patients (mean age 55.5±8.1 years) were followed up for a mean of 13.5±11.9 months following TIPS. Total psoas and paraspinal muscle area increased significantly (P<0.0001) after TIPS (from 22.8±0.9 to 25.1±0.9 cm and 54.5±1.3 to 57.9±1.5 cm, respectively). After TIPS, muscle area increased in 41 patients but remained unchanged or decreased in 16 patients. Post-TIPS visceral fat volume decreased significantly (47.7±4.1 to 40.5±3.4 cm; P<0.001). Failure to reverse sarcopenia after TIPS was accompanied by higher (P=0.007) mortality (43.5%) compared with patients in whom the total muscle area increased (9.8%). On multivariate analysis, predictors of reversal of sarcopenia after TIPS included male sex and lower pre-TIPS muscle area. Cirrhotic patients who did not undergo TIPS showed no change in the mean muscle area over 13.1±1.3 months.

CONCLUSION

TIPS reverses sarcopenia in cirrhotic patients. Failure to improve muscle area after TIPS was accompanied by a higher mortality.

摘要

背景

肌肉减少症是肝硬化最常见的并发症。经颈静脉肝内门体分流术 (TIPS) 可降低肝硬化患者的门静脉压力并改变身体成分。通过 CT 扫描在 TIPS 前后量化骨骼肌面积和脂肪组织体积的变化。

材料和方法

对 57 例接受 TIPS 前后进行 CT 扫描的连续肝硬化患者进行了研究。同时进行年龄匹配、性别匹配、Child 评分匹配和终末期肝病模型评分匹配(n=32)未接受 TIPS 的肝硬化患者和 57 例接受 CT 腹部检查的健康个体作为健康对照组。在 CT 扫描的 L4 椎体中部获得肌肉面积和脂肪体积。

结果

患者(平均年龄 55.5±8.1 岁)在 TIPS 后平均随访 13.5±11.9 个月。TIPS 后,总腰大肌和腰背肌面积显著增加(P<0.0001)(分别从 22.8±0.9cm 增加到 25.1±0.9cm 和从 54.5±1.3cm 增加到 57.9±1.5cm)。TIPS 后,41 例患者的肌肉面积增加,16 例患者的肌肉面积保持不变或减少。TIPS 后内脏脂肪体积显著减少(从 47.7±4.1cm 减少到 40.5±3.4cm;P<0.001)。TIPS 后肌肉减少症无法逆转的患者死亡率较高(43.5%),与肌肉总面积增加的患者(9.8%)相比(P=0.007)。多变量分析显示,TIPS 后肌肉减少症逆转的预测因素包括男性和较低的 TIPS 前肌肉面积。未接受 TIPS 的肝硬化患者在 13.1±1.3 个月内肌肉面积无变化。

结论

TIPS 可逆转肝硬化患者的肌肉减少症。TIPS 后肌肉面积未改善与死亡率升高有关。

相似文献

1
Reversal of sarcopenia predicts survival after a transjugular intrahepatic portosystemic stent.经颈静脉肝内门体分流术支架置入后肌减少症的逆转预测生存。
Eur J Gastroenterol Hepatol. 2013 Jan;25(1):85-93. doi: 10.1097/MEG.0b013e328359a759.
2
Psoas Muscle Density in Combination with Model for End-Stage Liver Disease Score Can Improve Survival Predictability in Transjugular Intrahepatic Portosystemic Shunts.腰大肌密度联合终末期肝病模型评分可提高经颈静脉肝内门体分流术的生存预测能力。
J Vasc Interv Radiol. 2019 Feb;30(2):154-161. doi: 10.1016/j.jvir.2018.10.006.
3
Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt.肌肉减少症与接受经颈静脉肝内门体分流术的失代偿期肝硬化发生慢加急性肝衰竭相关。
Clin Transl Gastroenterol. 2019 Apr;10(4):e00025. doi: 10.14309/ctg.0000000000000025.
4
Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.经颈静脉肝内门体分流术后患者生存的腰大肌密度预测:一项回顾性队列研究。
Med Sci Monit. 2022 Jan 15;28:e934057. doi: 10.12659/MSM.934057.
5
Sarcopenia is an independent risk factor for short-term mortality in patients undergoing transjugular intrahepatic portosystemic shunt.肌肉减少症是经颈静脉肝内门体分流术患者短期死亡率的独立危险因素。
Eur J Gastroenterol Hepatol. 2024 Aug 1;36(8):1010-1015. doi: 10.1097/MEG.0000000000002790. Epub 2024 May 27.
6
Combination of Model for End-Stage Liver Disease (MELD) and Sarcopenia predicts mortality after transjugular intrahepatic portosystemic shunt (TIPS).模型终末期肝病评分(MELD)和肌肉减少症联合预测经颈静脉肝内门体分流术(TIPS)后的死亡率。
Dig Liver Dis. 2024 Sep;56(9):1544-1550. doi: 10.1016/j.dld.2024.03.003. Epub 2024 Mar 29.
7
Increase of radiologically determined muscle area in patients with liver cirrhosis after transjugular intrahepatic portosystemic shunt.经颈静脉肝内门体分流术后肝硬化患者放射学确定的肌肉面积增加。
Sci Rep. 2023 Oct 10;13(1):17092. doi: 10.1038/s41598-023-43938-6.
8
Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.磁共振成像中无脂肪肌肉质量可预测代偿性肝硬化急性失代偿期肝衰竭和生存率。
Hepatology. 2018 Mar;67(3):1014-1026. doi: 10.1002/hep.29602. Epub 2018 Jan 24.
9
Sarcopenia is a risk factor for post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy and mortality: A systematic review and meta-analysis.肌肉减少症是经颈静脉肝内门体分流术肝性脑病和死亡率的一个风险因素:系统评价和荟萃分析。
Indian J Gastroenterol. 2024 Aug;43(4):748-759. doi: 10.1007/s12664-023-01465-2. Epub 2023 Dec 12.
10
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shunt.趋化因子(C-X-C基序)配体11水平可预测经颈静脉肝内门体分流术肝硬化患者的生存率。
Liver Int. 2016 Mar;36(3):386-94. doi: 10.1111/liv.12922. Epub 2015 Aug 17.

引用本文的文献

1
Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation.肌肉减少症作为经颈静脉肝内门体分流术(TIPS)植入患者的一个风险因素。
Diagnostics (Basel). 2025 Jun 5;15(11):1440. doi: 10.3390/diagnostics15111440.
2
Role of Nutrition in the Management of Chronic Liver Disease.营养在慢性肝病管理中的作用。
Gastro Hep Adv. 2025 Jan 2;4(5):100613. doi: 10.1016/j.gastha.2024.100613. eCollection 2025.
3
Value of systemic inflammation markers for the detection of minimal and prediction of overt hepatic encephalopathy after TIPS insertion.
经颈静脉肝内门体分流术(TIPS)术后全身炎症标志物对轻微型肝性脑病检测及显性肝性脑病预测的价值
Metab Brain Dis. 2024 Dec 10;40(1):58. doi: 10.1007/s11011-024-01436-2.
4
Quantitative Assessment of Body Composition in Cirrhosis.肝硬化患者身体成分的定量评估
Diagnostics (Basel). 2024 Sep 30;14(19):2191. doi: 10.3390/diagnostics14192191.
5
MRI paraspinous skeletal muscle enhancement: A potential imaging biomarker for assessing clinical liver cirrhosis severity.MRI 脊柱旁骨骼肌强化:评估临床肝硬化严重程度的潜在影像学生物标志物。
PLoS One. 2024 Aug 22;19(8):e0308520. doi: 10.1371/journal.pone.0308520. eCollection 2024.
6
Advances in the management of complications from cirrhosis.肝硬化并发症管理的进展
Gastroenterol Rep (Oxf). 2024 Aug 5;12:goae072. doi: 10.1093/gastro/goae072. eCollection 2024.
7
Frailty, Sarcopenia, and Nutrition in Patients With Cirrhosis.肝硬化患者的衰弱、肌肉减少症与营养
Gastroenterol Hepatol (N Y). 2024 Apr;20(4):244-246.
8
The pharmacology of exercise: Strategies and challenges in the optimization of functional status in cirrhosis.运动的药理学:肝硬化患者功能状态优化的策略与挑战
Clin Liver Dis (Hoboken). 2024 Apr 26;23(1):e0165. doi: 10.1097/CLD.0000000000000165. eCollection 2024 Jan-Jun.
9
Recent developments in the management of ascites in cirrhosis.肝硬化腹水管理的最新进展。
United European Gastroenterol J. 2024 Mar;12(2):261-272. doi: 10.1002/ueg2.12539. Epub 2024 Feb 10.
10
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic Opportunities.失代偿期肝硬化的营养不良和肌肉减少症相关门静脉高压症的发病机制、影响及治疗机会
Nutrients. 2023 Dec 21;16(1):35. doi: 10.3390/nu16010035.